About · Last updated 2026-04-13
About the site
Who we are, how we work, and who's accountable for what you read here.
Operator
Maren Calloway
Founder & Editor-in-Chief
Calloway spent a decade studying plant-derived alkaloids in Southeast Asian traditional medicine systems before shifting her focus to how those compounds interact with opioid and adrenergic receptors in Western clinical contexts. She founded 7-Hydroxymitragynine.co to apply that same research discipline to the consumer 7-OH market, where concentrated semi-synthetic products have outpaced the regulatory and scientific frameworks built for kratom leaf.
Contact [email protected]
Ownership and independence
7-Hydroxymitragynine.co is independently operated by Maren Calloway. The site has no affiliation with, funding from, or editorial influence by any 7-OH or kratom manufacturer, retailer, trade group, or pharmaceutical company.
We do not run affiliate links to 7-OH or kratom products. We do not accept sponsorship or paid placements. Brands and products covered on this site are described editorially; their coverage is not an endorsement and we have no commercial relationship with them.
How this site is researched
Every substantive claim on this site traces to a primary source — peer-reviewed research, government documents, court filings, or professional news reporting. Our editorial policy describes the sourcing hierarchy and review cadence. Our references page lists the peer-reviewed papers cited across the site.
We use large language models as a drafting and research tool on some pages. Every published claim is reviewed by a human editor against primary sources before publication; we do not publish unreviewed LLM output.
Corrections
If you believe something on this site is incorrect, please email [email protected] with the page URL and, where possible, a primary source. We aim to acknowledge corrections within seven days and to note material updates in the Revision history at the foot of the affected page.